Advertisement
Review Article| Volume 36, ISSUE 4, P825-837, December 2022

Download started.

Ok

Management of Unique Pneumonias Seen in the Intensive Care Unit

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Infectious Disease Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vincent J.L.
        • Sakr Y.
        • Singer M.
        • et al.
        Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017.
        JAMA. 2020; 323: 1478-1487
        • Storms A.D.
        • Chen J.F.
        • Jackson L.A.
        • et al.
        Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults.
        Bmc Pulm Med. 2017; 17: 208
      1. 2020 National and State Healthcare-Associated Infections Progress Report Last Updated: October 26, 2021. Available at: https://www.cdc.gov/hai/data/portal/progress-report.html. Accessed August 11, 2022.

        • Quinton L.J.
        • Walkey A.J.
        • Mizgerd J.P.
        Integrative Physiology of Pneumonia.
        Physiol Rev. 2018; 98: 1417-1464
        • Metlay J.P.
        • Waterer G.W.
        • Long A.C.
        • et al.
        Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.
        Am J Respir Crit Care Med. 2019; 200: e45-e67
      2. Pneumonia. Available at: https://www.cdc.gov/dotw/pneumonia/index.html. Last updated: October 8, 2021, viewed 8/11/227. Last updated 11 November 2021, viewed 8/11/2214. Last updated January 1, 2021, viewed 8/11/2216. Last updated October 22, 2020, viewed 8/11/22.

      3. Pneumonia.
        (Available at:)
        • Tablan O.
        • Anderson L.
        • Besser R.
        • et al.
        Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.
        MMWR Recomm Rep. 2004; 53: 1-36
        • Kalil A.C.
        • Metersky M.L.
        • Klompas M.
        • et al.
        Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.
        Clin Infect Dis. 2016; 63: 575-582
        • Koenig S.M.
        • Truwit J.D.
        Ventilator-associated pneumonia: diagnosis, treatment, and prevention.
        Clin Microbiol Rev. 2006; 19: 637-657
        • Kalanuria A.A.
        • Ziai W.
        • Mirski M.
        Ventilator-associated pneumonia in the ICU.
        Crit Care. 2014; 18: 208
        • He Q.
        • Wang W.
        • Zhu S.C.
        • et al.
        The epidemiology and clinical outcomes of ventilator-associated events among 20,769 mechanically ventilated patients at intensive care units: an observational study.
        Crit Care. 2021; 25
        • Klompas M.
        Ventilator-Associated Events: What They Are and What They Are Not.
        Respir Care. 2019; 64: 953-961
      4. Ventilator-associated Events (VAE).
        (Available at:)
        • Klompas M.
        Is a ventilator-associated pneumonia rate of zero really possible?.
        Curr Opin Infect Dis. 2012; 25: 176-182
      5. Causes of Pneumonia.
        (Available at:)
        • Verhamme K.M.
        • De Coster W.
        • De Roo L.
        • et al.
        Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia.
        Infect Control Hosp Epidemiol. 2007; 28: 389-397
      6. Appendix A.
        (Available at:)
        • Kalil A.C.
        • Metersky M.L.
        • Klompas M.
        • et al.
        Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.
        Clin Infect Dis. 2016; 63: e61-e111
        • Meersseman W.
        • Lagrou K.
        • Spriet I.
        • et al.
        Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study.
        Intensive Care Med. 2009; 35: 1526-1531
        • Richards M.J.
        • Edwards J.R.
        • Culver D.H.
        • et al.
        Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.
        Crit Care Med. 1999; 27: 887-892
        • Chow E.J.
        • Doyle J.D.
        • Uyeki T.M.
        Influenza virus-related critical illness: prevention, diagnosis, treatment.
        Crit Care. 2019; 23: 214
        • Dautzenberg M.J.D.
        • Wekesa A.N.
        • Gniadkowski M.
        • et al.
        The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study.
        Crit Care Med. 2015; 43: 1170-1177
        • Kim D.K.
        • Kim H.S.
        • Pinto N.
        • et al.
        Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital.
        Ann Lab Med. 2016; 36: 162-165
        • Pickens C.I.
        • Wunderink R.G.
        Principles and Practice of Antibiotic Stewardship in the ICU.
        Chest. 2019; 156: 163-171
        • Saied W.I.
        • Merceron S.
        • Schwebel C.
        • et al.
        Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome.
        J Infect. 2020; 80: 279-285
        • Forgie S.
        • Marrie T.J.
        Healthcare-associated atypical pneumonia.
        Semin Respir Crit Care Med. 2009; 30: 67-85
        • Fraser D.W.
        • Tsai T.R.
        • Orenstein W.
        • et al.
        Legionnaires' disease: description of an epidemic of pneumonia.
        N Engl J Med. 1977; 297: 1189-1197
        • Gamage S.D.
        • Ambrose M.
        • Kralovic S.M.
        • et al.
        Legionnaires Disease Surveillance in US Department of Veterans Affairs Medical Facilities and Assessment of Health Care Facility Association.
        JAMA Netw Open. 2018; 1: e180230
        • Ambrose M.
        • Kralovic S.M.
        • Roselle G.A.
        • et al.
        Implementation of Legionella Prevention Policy in Health Care Facilities: The United States Veterans Health Administration Experience.
        J Public Health Manag Pract. 2020; 26: E1-E11
        • Yu V.L.P.J.
        • Pastoris M.C.
        • Stout J.E.
        • et al.
        Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey.
        J Infect Dis. 2002; 186: 127-128
        • Phin N.
        • Parry-Ford F.
        • Harrison T.
        • et al.
        Epidemiology and clinical management of Legionnaires' disease.
        Lancet Infect Dis. 2014; 14: 1011-1021
        • Stout J.E.
        • Arnold B.
        • Yu V.L.
        Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
        J Antimicrob Chemother. 1998; 41: 289-291
        • Garcia-Vidal C.
        • Sanchez-Rodriguez I.
        • Simonetti A.F.
        • et al.
        Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis.
        Clin Microbiol Infect. 2017; 23: 653-658
        • Jasper A.S.
        • Musuuza J.S.
        • Tischendorf J.S.
        • et al.
        Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis.
        Clin Infect Dis. 2021; 72: 1979-1989
        • Murray H.W.
        • Tuazon C.
        Atypical pneumonias.
        Med Clin North Am. 1980; 64: 507-527
        • Waites K.B.
        • Xiao L.
        • Liu Y.
        • et al.
        Mycoplasma pneumoniae from the Respiratory Tract and Beyond.
        Clin Microbiol Rev. 2017; 30: 747-809
        • Nguyen C.
        • Kaku S.
        • Tutera D.
        • et al.
        Viral Respiratory Infections of Adults in the Intensive Care Unit.
        J Intensive Care Med. 2016; 31: 427-441
        • Kain T.
        • Fowler R.
        Preparing intensive care for the next pandemic influenza.
        Crit Care. 2019; 23: 337
        • St Charles K.M.
        • Ssematimba A.
        • Malladi S.
        • et al.
        Avian Influenza in the U.S. Commercial Upland Game Bird Industry: An Analysis of Selected Practices as Potential Exposure Pathways and Surveillance System Data Reporting.
        Avian Dis. 2018; 62: 307-315
        • Muthuri S.G.
        • Venkatesan S.
        • Myles P.R.
        • et al.
        Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
        Lancet Respir Med. 2014; 2: 395-404
        • Klinger J.R.
        • Sanchez M.P.
        • Curtin L.A.
        • et al.
        Multiple cases of life-threatening adenovirus pneumonia in a mental health care center.
        Am J Respir Crit Care Med. 1998; 157: 645-649
        • Midgley C.M.
        • Jackson M.A.
        • Selvarangan R.
        • et al.
        Severe respiratory illness associated with enterovirus D68 - Missouri and Illinois, 2014.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 798-799
        • Colson P.
        • Aherfi S.
        • La Scola B.
        • et al.
        The role of giant viruses of amoebas in humans.
        Curr Opin Microbiol. 2016; 31: 199-208
        • Rayamajhee B.
        • Dinesh Subedi D.
        • Peguda H.K.
        • et al.
        A Systematic Review of Intracellular Microorganisms within Acanthamoeba to Understand Potential Impact for Infection.
        Pathogens. 2021; 10: 225
        • Koehler P.B.M.
        • Chakrabarti A.
        • Chen S.C.A.
        • et al.
        European Confederation of Medical Mycology; International Society for Human Animal Mycology; Asia Fungal Working Group; INFOCUS LATAM/ISHAM Working Group; ISHAM Pan Africa Mycology Working Group; European Society for Clinical Microbiology; Infectious Diseases Fungal Infection Study Group; ESCMID Study Group for Infections in Critically Ill Patients; Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy; Medical Mycology Society of Nigeria; Medical Mycology Society of China Medicine Education Association; Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology; Association of Medical Microbiology; Infectious Disease Canada. : Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
        Lancet Infect Dis. 2021; 21: e149-e162
        • Wauters J.
        • Baar I.
        • Meersseman P.
        • et al.
        Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study.
        Intensive Care Med. 2012; 38: 1761-1768
        • Chen F.
        • Danyal Qasir D.
        • Morris A.C.
        Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias.
        Semin Respir Crit Care Med. 2022; 43: 234-242
        • Kluge S.
        • Strauß R.
        • Kochanek M.
        • et al.
        Aspergillosis: Emerging risk groups in critically ill patients.
        Med Mycol. 2021; 60: myab064
        • Sader H.S.
        • Castanheira M.
        • Ryan Arends S.J.
        • et al.
        Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997-2016).
        J Antimicrob Chemother. 2019; 74: 1595-1606
        • Mergenhagen K.A.S.K.
        • Wattengel B.A.
        • Lesse A.J.
        • et al.
        Determining the Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening in Antimicrobial Stewardship.
        Clin Infect Dis. 2020; 71: 1142-1148